SEARCH

SEARCH BY CITATION

References

  • 1
    Siringo S, Di Febo G, Bolondi L, Sofia S, Gaiani A, Rigamonti M, Miglioli G, et al. Circadian occurrence of variceal bleeding in cirrhotics [Abstract]. Gastroenterology 1992; 102: 890A.
  • 2
    Merican I, Sprengers D, McCormick PA, Minoli G, McIntyre N, Burroughs AK. Diurnal pattern of variceal bleeding in patients with cirrhosis. J Hepatol 1993; 19: 1522.
  • 3
    Garcia Pagan JC, Feu F, Castells A, Luca A, Hermida R, Rivera F, Bosch J, et al. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis. Hepatology 1994; 19: 595601.
  • 4
    Alvarez D, Golombek D, Lopez P, de las Heras M, Viola L, Sanchez S, Kolker M, et al. Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis. Hepatology 1994; 20: 11981203.
  • 5
    Lebrec D, Hillon P, Munoz C, Goldfarg G, Nauel O, Benhamou JP. The effects of propranolol on portal hypertension in patients with cirrhosis. A hemodynamic study. Hepatology 1982; 2: 523527.
  • 6
    Bosch J, Mastai R, Kravetz D, Bruix J, Gaya J, Rigau J, Rodes J. Effects of propranolol on azygos blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 12001205.
  • 7
    Lebrec D, Poynard T, Bernau J, Bercoff E, Novel O, Capron JP, Poupon R, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355358.
  • 8
    Conn HO, Grace N, Bosch J, Groszmann R, Rodes J, Wright S, Matloff D, et al. Propranolol in the prevention of the first hemorrhage from esopha-gogastric varices. A multicenter, randomized, clinical trial. Hepatology 1991; 13: 902912.
  • 9
    Editorial. Diurnal variation in platelet aggregation responses [Editorial]. Lancet 1988; 2: 14051406.
  • 10
    Brezinski DA, Tolfer GH, Muller JE. Morning increase in platelet aggregability: association with assumption of the upright posture. Circulation 1988; 78: 3540.
  • 11
    Alvarez D, Mastai R, Lennie A, Soifer G, Levi D, Terg R. Noninvasive measurement of portal venous blood flow in patients with cirrhosis: effects of physiological and pharmacological stimuli. Dig Dis Sci 1992; 36: 8286.
  • 12
    Zoli M, Marchesini G, Brunoni A, Cordaini R, Pisi E. Portal venous blood flow in response to acute beta blockers and vasodilatory treatment in patients with liver cirrhosis. Hepatology 1986; 6: 12481251.
  • 13
    Sabba C, Weltin G, Cichetti DV, Ferraioli G, Taylor K, Nakamura T, Moriyasu F, et al. Observer variability in echo-Doppler measurements of portal blood flow in cirrhotic patients and normal volunteers. Gastroenterology 1990; 98: 16031611.
  • 14
    Vorobioff J, Picabea E, Villavicencio R, Pucini V, Rossi O, Bordato J, Audato M. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 1987; 7: 648653.
  • 15
    Sabba C, Ferraioli G, Buonamico P, Mahl T, Taylor K, Lenner E, Albano O, et al. A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients. Gastroenterology 1992; 102: 10091016.
  • 16
    Hillon P, Lebrec D, Munoz C, Jungens M, Goldfarb G, Benhamou JP. Comparison of cardioselective and non selective beta-blocker on portal hypertension in patients with cirrhosis. Hepatology 1982; 2: 528531.
  • 17
    Henriksen J, Ring-Larsen H, Cristensen N. Propranolol in gastrointestinal bleeding [letter]. N Engl J Med 1982; 306: 1551.
  • 18
    Mastai R, Bosch J, Navasa M, Kravetz D, Bruix J, Viola C, Rodes J. Effects of adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic hemodynamics in patients with cirrhosis. J Hepatol 1987; 4: 7179.
  • 19
    Arroyo V, Planas R, Gaya J, Deulofeu R, Rivera F, Rodes J. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prosta-glandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983; 13: 271278.